HWK-007
HWK-007-101
Phase 1 small_molecule active
Quick answer
HWK-007 for Endometrial Cancer is a Phase 1 program (small_molecule) at Whitehawk Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Whitehawk Therapeutics
- Indication
- Endometrial Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active